all 1 comments

[–]Maniak🥃😾[S] 1 insightful - 1 fun1 insightful - 0 fun2 insightful - 1 fun -  (0 children)

Aurobindo Pharma Ltd wants to discontinue a late-stage trial of molnupiravir in moderate COVID-19 patients, the regulator's expert committee said on Friday.

"There is no significant efficacy against moderate COVID and the effective efficacy is towards mild cases," the source said on condition of anonymity due to the sensitive nature of the discussions.

Ineffective, and unsafe due to its mutagenic aspect. Hey, at least the donor-sponsored C19 'measures' are consistent.